Casdin Eli's Form 4 filing
GeneDx Holdings Corp. (WGS) · filed Feb 2, 2023
- Accession no.
- 0000899243-23-003400
- Filed
- Feb 2, 2023, 4:05 PM ET
- Trade date
- Jan 31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $30.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Casdin EliCIK 0001534264 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Class A Common Stock | PPurchaseAcquired | +71,428,542 | $0.35 | +$24,999,989.7 | 87,866,042 | Indirect | |
| Jan 31, 2023 | Class A Common Stock | PPurchaseAcquired | +14,285,743 | $0.35 | +$5,000,010.05 | 14,285,743 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.